Defining new therapeutics using a more immunocompetent mouse model of antibody-enhanced dengue virus infection

Authors

Amelia K. Pinto, Washington University School of Medicine in St. Louis
James D. Brien, Washington University School of Medicine in St. Louis
Chia-Ying Kao Lam, MacroGenics, Inc.Follow
Syd Johnson, MacroGenics, Inc.
Cindy Chiang, Pasteur Institute of Rome
John Hiscott, Pasteur Institute of RomeFollow
Vanessa V. Sarathy, University of Texas Medical Branch
Alan D. Barrett, University of Texas Medical Branch
Sujan Shresta, La Jolla Institute for Allergy and Immunology
Michael S. Diamond, Washington University School of Medicine in St. LouisFollow

Journal

mBio

Publication Date

2015

Volume

6

Issue

5

Inclusive Pages

e01316-15

Document Type

Open Access Publication

DOI

10.1128/mBio.01316-15

Rights and Permissions

Pinto AK, Brien JD, Lam C-YK, Johnson S, Chiang C, Hiscott J, Sarathy VV, Barrett AD, Shresta S, Diamond MS. 2015. Defining new therapeutics using a more immunocompetent mouse model of antibody-enhanced dengue virus infection. mBio 6(5):e01316-15. doi:10.1128/mBio.01316-15.

Recommended Citation

Pinto, Amelia K.; Brien, James D.; Lam, Chia-Ying Kao; Johnson, Syd; Chiang, Cindy; Hiscott, John; Sarathy, Vanessa V.; Barrett, Alan D.; Shresta, Sujan; and Diamond, Michael S., "Defining new therapeutics using a more immunocompetent mouse model of antibody-enhanced dengue virus infection." mBio. 6, 5. e01316-15. (2015).
https://digitalcommons.wustl.edu/open_access_pubs/4213